Students

Jame Frénay graduated as a pharmacist (PharmD) from the University of Burgundy in 2021. He has been a member of the IMATHERa team since 2020, with whom he has worked on several projects as an intern and then on contract: study of a theranostic agent targeting the IL-1RAP protein in leukemia, study of a theranostic agent targeting the CD38 protein in myeloma and lymphoma, study of agents for guided surgery and photodynamic therapy.

Since January 2023, Jame Frénay has been working on a chemistry thesis (ICE grant – Itinéraire Chercheur Entrepreneur) within the IMATHERa team and the ICB laboratory (Institut Carnot de Bourgogne) on the imaging and monitoring of cell therapies (such as CAR-T cells) used in the treatment of leukemia. His work focuses on monitoring CAR-T cell therapies in solid tumor and leukemia models using medical imaging (PET/MRI and SPECT/CT). He is also working on optimizing the selection of T lymphocytes used in CAR-T therapy in order to increase its efficacy, notably via flow cytometry techniques.